Alternatives to Januvia If You Can't Fill Your Prescription

Januvia (sitagliptin) is one of the most widely prescribed medications for type 2 diabetes, but its high cost and brand-name-only status can make it difficult for some patients to access consistently. If you can't fill your Januvia prescription — whether due to cost, availability, or insurance denial — you may have more options than you think.

Always talk to your doctor before switching medications. Blood sugar management is highly individual, and what works best depends on your specific situation, kidney function, other medications, and health history. This guide is for informational purposes to help you have an informed conversation with your healthcare provider.

Same Drug Class: Other DPP-4 Inhibitors (Gliptins)

Januvia belongs to the dipeptidyl peptidase-4 (DPP-4) inhibitor class. There are three other FDA-approved DPP-4 inhibitors that work through the same mechanism. Switching within this class requires the fewest treatment adjustments.

Tradjenta (Linagliptin) — Best for Kidney Disease

Tradjenta (linagliptin) is a DPP-4 inhibitor with a key advantage: it is primarily eliminated through bile and the gut rather than the kidneys. This means no dose adjustment is needed for patients with chronic kidney disease (CKD), making it a preferred alternative for patients with significant renal impairment. Like Januvia, Tradjenta is brand-name only, so cost can be a barrier. It is taken as a 5 mg tablet once daily.

Onglyza (Saxagliptin) — Generic Available

Onglyza (saxagliptin) is a DPP-4 inhibitor with an important consideration: clinical trials (the SAVOR-TIMI 53 study) showed a small but statistically significant increased risk of heart failure hospitalization. For this reason, saxagliptin is generally not recommended for patients with existing heart failure or at high risk for it. However, generic saxagliptin is now available, making it significantly less expensive than Januvia. Standard dose is 2.5–5 mg once daily.

Nesina (Alogliptin) — Another Generic Option

Nesina (alogliptin) is another DPP-4 inhibitor available as a generic. Like saxagliptin, alogliptin has shown a potential signal for increased heart failure hospitalization risk and carries an FDA warning. Dose is 25 mg once daily for patients with normal kidney function. Its lower cost as a generic makes it a budget-friendly DPP-4 alternative.

Zituvio (Sitagliptin Free Base) — Closest Alternative to Januvia

Zituvio (sitagliptin, by Zydus Pharmaceuticals) was FDA-approved in October 2023. It contains the same active ingredient as Januvia — sitagliptin — but uses a different chemical form (free base rather than phosphate salt). Zituvio is not bioequivalent to Januvia and cannot be automatically substituted, but your doctor can write a new prescription for it. At select specialty pharmacies like Marley Drug, Zituvio (as an authorized generic sitagliptin) can cost around $80/month.

Different Drug Class: SGLT2 Inhibitors

If a DPP-4 inhibitor isn't the right fit or isn't accessible, SGLT2 inhibitors represent another class of oral diabetes medication. These include Jardiance (empagliflozin) and Farxiga (dapagliflozin). SGLT2 inhibitors work by preventing kidneys from reabsorbing glucose, causing it to be excreted in urine. They also carry proven cardiovascular and kidney protective benefits for patients with existing heart or kidney disease. Some SGLT2 inhibitors now have generics available. They do carry a risk of urinary tract infections and yeast infections.

Different Drug Class: GLP-1 Receptor Agonists

GLP-1 receptor agonists like Ozempic (semaglutide), Trulicity (dulaglutide), and Victoza (liraglutide) are injectable medications that lower blood sugar, reduce appetite, and often result in weight loss. They typically produce stronger A1C reductions than DPP-4 inhibitors (1–2% vs. 0.4–0.9%) and have proven cardiovascular benefits. If Januvia isn't working well enough or isn't accessible, your doctor might consider a GLP-1 agent — though they require injection and are also expensive without insurance.

Back to Basics: Metformin

Metformin remains the first-line medication for type 2 diabetes according to American Diabetes Association guidelines, and its generic form costs as little as $4–$10 per month. If you were using Januvia as an add-on to metformin, discuss with your doctor whether adjusting your metformin dose or adding another affordable generic might bridge the gap while access issues are resolved.

What If I Simply Can't Afford or Access Januvia Right Now?

Before switching medications, exhaust your access options. Merck's savings card can reduce your Januvia cost to as little as $5/fill (for commercially insured patients). The Merck Patient Assistance Program may provide Januvia free of charge for uninsured or low-income patients. And medfinder can help locate pharmacies that have Januvia in stock near you.

See our full guide on how to save money on Januvia for a detailed breakdown of all available programs.

DPP-4 Inhibitor Comparison at a Glance

Januvia (sitagliptin): 100 mg once daily; brand-name; ~$600–700/month retail; neutral on heart failure

Tradjenta (linagliptin): 5 mg once daily; brand-name; no renal dose adjustment; neutral on heart failure

Onglyza (saxagliptin): 2.5–5 mg once daily; generic available; heart failure warning

Nesina (alogliptin): 25 mg once daily; generic available; heart failure warning

Zituvio (sitagliptin free base): Same active ingredient as Januvia; ~$80–$110/month at select pharmacies; requires new prescription